Table 5

Frequency, average severity, and average duration of episodes of lower respiratory tract infection during treatment

Mean (SD)MedianRangeDifference (95%CI)*Significance
Frequency (No/year)
Beclomethasone dipropionate (n=50)6.5 (4.5)6.10-20.5−0.3 (−2.2 to 1.5)t92=0.35, P=0.7
Placebo (n=44)6.9 (4.5)6.70-22.7
Average severity (maximum score)
Beclomethasone dipropionate (n=50)4.5 (2.3)4.20-10.5−0.5 (−1.4 to 0.4)t92=1.03, P=0.3
Placebo (n=44)5.0 (2.3)4.60-10.0
Average duration (days)
Beclomethasone dipropionate (n=50)8.4 (6.7)7.40-38.00.5 (−1.9 to 2.9)t92=0.43, P=0.7
Placebo (n=44)7.9 (4.7)6.60-22.5
  • * Beclomethasone dipropionate minus placebo.